Search research articles
Contact Us
Filters
Showing results (41-50 of 53) with videos related to
Page
of 6
Sort By:
Environmental Geochemistry and Health
|
April 10, 2026
Lung cancer risk in relation to indicative radon atlas metrics in Northern Ireland: a population-based case-control study using secondary data
Claire M Delargy, Helen G Coleman, Quentin G Crowley, et al.
BMC Cancer
|
October 17, 2019
Quality of life among symptomatic compared to PSA-detected prostate cancer survivors - results from a UK wide patient-reported outcomes study
David W Donnelly, Linda C Vis, Therese Kearney, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 15, 2024
Incidence and prognosis of cutaneous melanoma in European adolescents and young adults (AYAs): EUROCARE-6 retrospective cohort results
Alice Indini, Fabio Didoné, Daniela Massi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 11, 2025
Corrigendum to "Incidence and prognosis of cutaneous melanoma in European adolescents and young adults (AYAs): EUROCARE-6 retrospective cohort results" [Eur J Cancer 213 (2024):115079]
Alice Indini, Fabio Didoné, Daniela Massi, et al.
JAMA Ophthalmology
|
October 10, 2024
Survival and Health Care Burden of Children With Retinoblastoma in Europe
Gianni Virgili, Riccardo Capocaccia, Laura Botta, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 31, 2025
Skin melanoma survival is improving in Europe but regional differences persist: Results of the EUROCARE-6 study
Emanuele Crocetti, Damien Bennett, Valérie Jooste, et al.
The Lancet. Oncology
|
May 4, 2024
Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study
Milena Sant, Claudia Vener, Roberto Lillini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 23, 2025
Incidence and survival of European adolescents and young adults diagnosed with sarcomas: EUROCARE-6 results
Annalisa Trama, Paolo Lasalvia, Dan Stark, et al.
Lancet (London, England)
|
October 25, 2025
Global variation in patterns of care and time to initial treatment for breast, cervical, and ovarian cancer from 2015 to 2018 (VENUSCANCER): a secondary analysis of individual records for 275 792 women from 103 population-based cancer registries in 39 countries and territories
Claudia Allemani, Pamela Minicozzi, Bozena Morawski, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 8, 2025
Long-term survival for myeloid neoplasms and national health expenditure: A EUROCARE-6 retrospective, population-based study
Claudia Vener, Roberto Lillini, Roberta De Angelis, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 53) with videos related to
Sort By:
Page
of 6
Environmental Geochemistry and Health
|
April 10, 2026
Lung cancer risk in relation to indicative radon atlas metrics in Northern Ireland: a population-based case-control study using secondary data
Claire M Delargy, Helen G Coleman, Quentin G Crowley, et al.
BMC Cancer
|
October 17, 2019
Quality of life among symptomatic compared to PSA-detected prostate cancer survivors - results from a UK wide patient-reported outcomes study
David W Donnelly, Linda C Vis, Therese Kearney, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 15, 2024
Incidence and prognosis of cutaneous melanoma in European adolescents and young adults (AYAs): EUROCARE-6 retrospective cohort results
Alice Indini, Fabio Didoné, Daniela Massi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 11, 2025
Corrigendum to "Incidence and prognosis of cutaneous melanoma in European adolescents and young adults (AYAs): EUROCARE-6 retrospective cohort results" [Eur J Cancer 213 (2024):115079]
Alice Indini, Fabio Didoné, Daniela Massi, et al.
JAMA Ophthalmology
|
October 10, 2024
Survival and Health Care Burden of Children With Retinoblastoma in Europe
Gianni Virgili, Riccardo Capocaccia, Laura Botta, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 31, 2025
Skin melanoma survival is improving in Europe but regional differences persist: Results of the EUROCARE-6 study
Emanuele Crocetti, Damien Bennett, Valérie Jooste, et al.
The Lancet. Oncology
|
May 4, 2024
Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study
Milena Sant, Claudia Vener, Roberto Lillini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 23, 2025
Incidence and survival of European adolescents and young adults diagnosed with sarcomas: EUROCARE-6 results
Annalisa Trama, Paolo Lasalvia, Dan Stark, et al.
Lancet (London, England)
|
October 25, 2025
Global variation in patterns of care and time to initial treatment for breast, cervical, and ovarian cancer from 2015 to 2018 (VENUSCANCER): a secondary analysis of individual records for 275 792 women from 103 population-based cancer registries in 39 countries and territories
Claudia Allemani, Pamela Minicozzi, Bozena Morawski, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 8, 2025
Long-term survival for myeloid neoplasms and national health expenditure: A EUROCARE-6 retrospective, population-based study
Claudia Vener, Roberto Lillini, Roberta De Angelis, et al.
Page
of 6